Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Charles Schwab Q1 Net Profit Up, But EPS Flat - Quick Facts

RELATED NEWS
Trade SCHW now with 

Brokerage and investment manager Charles Schwab Corp. (SCHW: Quote) reported higher first-quarter net income available to common stockholders of $198 million, versus $195 million a year ago, with earnings per share remaining flat at $0.15 per share. Also, quarterly net income grew 6% to $206 million, from the prior-year quarter's $195 million.

On average, 23 analysts polled by Thomson Reuters expected earnings per share of $0.16 for the quarter. Analysts' estimates typically exclude one-time items.

Total net revenues were $1.29 billion in the first quarter, up 8% from $1.19 billion last year, while it beat consensus estimate of $1.27 billion.

Click here to receive FREE breaking news email alerts for Charles Schwab and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.